Empinado, Bb Boy .
HRN: 26-16-11 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/01/2024
11/08/2024
IV DRIP
60mg
Q12
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes